NCT00004203: Oxaliplatin in Treating Patients With Metastatic Bladder Cancer |
|
|
| Completed | 2 | 20 | US, Canada | oxaliplatin | University of Chicago, National Cancer Institute (NCI) | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | 02/02 | 04/05 | | |
NCT00627432: Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer |
|
|
| Suspended | 2 | 100 | Europe | gemcitabine hydrochloride, oxaliplatin | Institut du Cancer de Montpellier - Val d'Aurelle | Bladder Cancer | 03/09 | | | |
NCT03159143: Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract |
|
|
| Completed | 2 | 22 | US | Docetaxel, Taxotere, Oxaliplatin | Leonard Appleman, Sanofi-Synthelabo | Metastatic Transitional Cell Cancer of the Urothelial Tract | 06/09 | 12/09 | | |
